Evidence map›Paper›PMID 40563427›Full record

ArticleBiomolecules2025

Neuronal Deletion of

Will P Walker, Megan Lea Ratz-Mitchem, Kay-Uwe Wagner, Teresa M Gunn

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Will P WalkerMcLaughlin Research Institute, Great Falls, MT 59405, USA.
Megan Lea Ratz-MitchemMcLaughlin Research Institute, Great Falls, MT 59405, USA.
Kay-Uwe WagnerDepartment of Oncology, Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48202, USA.ORCID 0000-0002-5081-0226
Teresa M GunnMcLaughlin Research Institute, Great Falls, MT 59405, USA.ORCID 0000-0003-2688-6420

Funding

Modulation of Exosome Release for Functional Restoration in Age-related Retinal DisordersP20GM152335 · NIGMS · MC LAUGHLIN RESEARCH INSTITUTE · PI Renee A Reijo Pera · 2024 to 2026
$11.1M
McLaughlin Research Institute institutional fundsNIGMS NIH HHS P20 GM152335
6 · The paper itself

Abstract

Endosomal dysfunction is one of the earliest cellular signs in Alzheimer's disease. Tumor susceptibility gene 101 protein (TSG101) is a component of the endosomal sorting complex required for transport (ESCRT)-I, which plays a key role in sorting ubiquitinated cell surface proteins and lipids onto intraluminal vesicles of multivesicular bodies for trafficking to lysosomes or autophagosomes for degradation, or to the plasma membrane for exosomal secretion. TSG101-dependent trafficking has been implicated in the propagation and spread of misfolded proteins associated with neurodegenerative diseases. We used transgenesis mice to study the in vivo consequences of disrupting TSG101-dependent trafficking in adult neurons. Mice lacking

Indexed as

ApoptosisCA3 Region, HippocampalDNA-Binding ProteinsEndosomal Sorting Complexes Required for TransportNeuronsTranscription FactorsAnimalsAutophagyEndosomesGene DeletionMiceMice, KnockoutSequestosome-1 ProteinTsg101 ProteinDNA-Binding ProteinsEndosomal Sorting Complexes Required for TransportSequestosome-1 ProteinTranscription FactorsTsg101 Proteinamyloid betaendosomal traffickingneurodegenerationTumor Susceptibility Gene 101 (Tsg101/TSG101)

Identifiers

PMID40563427
PMCPMC12191344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.